Randomized clinical trial of laparoscopic ultrasonography before laparoscopic colorectal cancer resection

Ellebæk, Signe Bremholm; Fristrup, Claus Wilki; Hovendal, Claus; Qvist, Niels; Bundgaard, Lars; Salomon, Søren; Støvring, Jens; Mortensen, Michael Bau

doi:10.1002/bjs.10636

Cited by 4 publications

(2 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In our experience, LLR for multinodular HCC is safe and feasible. However, some precautions are essential to reaching adequate oncologic outcomes, such as a high expertise in ultrasonography-guided parenchymal dissection with intraoperative ICG-guided fluorescence that can further help detect HCC nodules and guide difficult parenchymal dissection, while 3D-high definition scopes could represent an additional supportive visual tool [ 91 , 92 ]. Further technological research is supposed to help surgeons in this scenario, such as the application of 3-D preoperative modeling and virtual realities, which could also be beneficial in this context [ 93 ].…”

Section: Minimally Invasive Approach For Multiple Hepatocellular Carc...mentioning

confidence: 99%

Selecting the Best Approach for the Treatment of Multiple Non-Metastatic Hepatocellular Carcinoma

Cassese

Han

Cho

et al. 2022

Cancers

View full text Add to dashboard Cite

According to the Barcelona Clinic Liver Cancer (BCLC) staging system, the optimal strategy for patients with multiple HCC within the Milan Criteria is liver transplantation (LT). However, LT cannot be offered to all the patients due to organ shortages and long waiting lists, as well as because of the advanced disease carrying a high risk of poor outcomes. For early stages, liver resection (LR) or thermal ablation (TA) can be proposed, while trans-arterial chemoembolization (TACE) still remains the treatment of choice for intermediate stages (BCLC-B). Asian guidelines and the National Comprehensive Cancer Network suggest LR for resectable multinodular HCCs, even beyond Milan criteria. In this scenario, a growing body of evidence shows better outcomes after surgical resection when compared with TACE. Trans-arterial radioembolization (TARE) and stereotaxic body radiation therapy (SBRT) can also play an important role in this setting. Furthermore, the role of minimally invasive liver surgery (MILS) specifically for patients with multiple HCC is still not clear. This review aims to summarize current knowledge about the best therapeutical strategy for multiple HCC while focusing on the role of minimally invasive surgery and on the most attractive future perspectives.

show abstract

Section: Minimally Invasive Approach For Multiple Hepatocellular Carc...mentioning

confidence: 99%

Selecting the Best Approach for the Treatment of Multiple Non-Metastatic Hepatocellular Carcinoma

Cassese

Han

Cho

et al. 2022

Cancers

View full text Add to dashboard Cite

show abstract

“…These data are indeed convincing and speak for the long experience of these centers in complex laparoscopic liver surgery. Without any question, a broad experience in sonography-guided parenchymal dissection is indispensable [50]. 3D laparoscopy, as is standard practice at the Hôpital Pitié-Salpêtrière in Paris, should be mentioned as an another example for important supportive visual techniques.…”

Section: Multiple Bilobar Liver Metastasesmentioning

confidence: 99%

Laparoscopic liver resection: indications, limitations, and economic aspects

Schmelzle

Krenzien

Schöning

et al. 2020

Langenbecks Arch Surg

View full text Add to dashboard Cite

Background Minimally invasive techniques have increasingly found their way into liver surgery in recent years. A multitude of mostly retrospective analyses suggests several advantages of laparoscopic over open liver surgery. Due to the speed and variety of simultaneous technical and strategic developments, it is difficult to maintain an overview of the current status and perspectives in laparoscopic liver surgery. Purpose This review highlights up-to-date aspects in laparoscopic liver surgery. We discuss established indications with regard to their development over time as well as continuing limitations of applied techniques. We give an assessment based on the current literature and according to our own center experiences, not least with regard to a highly topical cost discussion. Conclusions While in the beginning mainly benign tumors were laparoscopically operated on, liver metastasis and hepatocellular carcinoma are now among the most frequent indications. Technical limitations remain and should be evaluated with the overall aim not to endanger quality standards in open surgery. Financial aspects cannot be neglected with the necessity of cost-covering reimbursement.

show abstract

The Role of Laparoscopic Surgery in the Management of Hepatocellular Carcinoma

Steggerda,

Wisel,

Nissen

et al. 2024

Curr Hepatology Rep

View full text Add to dashboard Cite

Purpose of Review Hepatocellular carcinoma (HCC) is the most common primary liver tumor and 6th most common cancer overall. This article reviews the role of laparoscopy in the multi-disciplinary management of HCC. Recent Findings Laparoscopic surgery involves multiple approaches for diagnosis and treatment of HCC, including intraoperative ultrasound and biopsy, as well as ablative strategies for tumors in difficult locations. In comparison to catheter-based therapies, hepatic resection offers similar survival with the benefit of direct visualization to identify additional tumors. Laparoscopic liver resections further show similar oncologic outcomes with reduced hospital length of stay and reduced morbidity compared to open approaches and may even be used to treat large tumors. Summary Laparoscopic surgery may be involved in the diagnosis, treatment, and resection of HCC. Laparoscopic hepatic resections are safe with equivalent oncologic outcomes and may offer advantages over catheter-based therapies in selected patients. Advances in robotic surgery have served to expand the potential for minimally invasive approaches in the surgical treatment of HCC.

show abstract

Randomized clinical trial of laparoscopic ultrasonography before laparoscopic colorectal cancer resection

Abstract: Routine LUS during resection of colorectal cancer is not recommended. Registration number: NCT02079389 (http://www.clinicaltrials.gov).

Cited by 4 publications

References 30 publications

Selecting the Best Approach for the Treatment of Multiple Non-Metastatic Hepatocellular Carcinoma

Selecting the Best Approach for the Treatment of Multiple Non-Metastatic Hepatocellular Carcinoma

Laparoscopic liver resection: indications, limitations, and economic aspects

The Role of Laparoscopic Surgery in the Management of Hepatocellular Carcinoma

Contact Info

Product

Resources

About